Nouri Pouneh, Gill Pritmohinder, Li Min, Wilcox Christopher S, Welch William J
Department of Medicine, Georgetown University, Washington, District of Columbia 20057, USA.
Am J Physiol Heart Circ Physiol. 2007 Apr;292(4):H1685-9. doi: 10.1152/ajpheart.00976.2006. Epub 2007 Jan 12.
Angiotensin II (ANG II) infusion increases renal superoxide (O(2)(-)) and enhances renal vasoconstriction via macula densa (MD) regulation of tubuloglomerular feedback, but the mechanism is unclear. We targeted the p22(phox) subunit of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) with small-interfering RNA (siRNA) to reduce NADPH oxidase activity and blood pressure response to ANG II in rats. We compared single nephron glomerular filtration rate (SNGFR) in samples collected from the proximal tubule (PT), which interrupts delivery to the MD, and from the distal tubule (DT), which maintains delivery to the MD, to assess MD regulation of GFR. SNGFR was measured in control and ANG II-infused rats (200 ng.kg(-1).min(-1) for 7 days) 2 days after intravenous injection of vehicle or siRNA directed to p22(phox) to test the hypothesis that p22(phox) mediates MD regulation of SNGFR during ANG II. The regulation of SNGFR by MD, determined by PT SNGFR-DT SNGFR, was not altered by siRNA in control rats (control + vehicle, 13 +/- 1, n = 8; control + siRNA, 12 +/- 2 nl/min, n = 8; not significant) but was reduced by siRNA in ANG II-treated rats (ANG II + vehicle, 13 +/- 2, n = 7; ANG II + siRNA, 7 +/- 1 nl/min, n = 8; P < 0.05). We conclude that p22(phox) and NADPH oxidase regulate the SNGFR during ANG II infusion via MD-dependent mechanisms.
输注血管紧张素II(ANG II)可增加肾脏超氧化物(O(2)(-)),并通过致密斑(MD)对肾小管-肾小球反馈的调节增强肾血管收缩,但具体机制尚不清楚。我们用小干扰RNA(siRNA)靶向烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶(NOX)的p22(phox)亚基,以降低NADPH氧化酶活性及大鼠对ANG II的血压反应。我们比较了从近端小管(PT,其中断向MD的物质输送)和远端小管(DT,其维持向MD的物质输送)采集的样本中的单肾单位肾小球滤过率(SNGFR),以评估MD对肾小球滤过率(GFR)的调节。在静脉注射载体或针对p22(phox)的siRNA 2天后,测量对照大鼠和输注ANG II的大鼠(200 ng·kg(-1)·min(-1),持续7天)的SNGFR,以检验p22(phox)在ANG II作用期间介导MD对SNGFR调节的假说。由PT SNGFR - DT SNGFR确定的MD对SNGFR的调节,在对照大鼠中不受siRNA影响(对照 + 载体,13 ± 1,n = 8;对照 + siRNA,12 ± 2 nl/min,n = 8;无显著差异),但在接受ANG II治疗的大鼠中被siRNA降低(ANG II + 载体,13 ± 2,n = 7;ANG II + siRNA,7 ± 1 nl/min,n = 8;P < 0.05)。我们得出结论,p22(phox)和NADPH氧化酶在ANG II输注期间通过MD依赖性机制调节SNGFR。